S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma

Author(s):
Claudia MaletzkiClaudia Maletzki1, Peggy  BodammerPeggy Bodammer3, Anne BreitrckAnne Breitrck4, Claus  KerkhoffClaus Kerkhoff4,*
1Department of General Surgery, Division of Molecular Oncology and Immunotherapy, University of Rostock, Germany
3Fraunhofer Institute for Cell Therapy and Immunology, Department of Immunology, AG Extracorporeal Immune Modulation (EXIM), Germany
4Department of Internal Medicine, Division of Nephrology, University of Rostock, [email protected], Germany

Hepatitis Monthly:Vol. 12, issue 10; 7240
Published online:Oct 12, 2012
Article type:Review Article
Received:Jun 02, 2012
Accepted:Jul 16, 2012
How to Cite:Maletzki C, Bodammer P, Breitrck A, Kerkhoff C. S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma. Hepat Mon. 2012;12(10):7240. doi: https://doi.org/10.5812/hepatmon.7240

Abstract

Context:

Clinical and experimental studies have suggested a link between S100 gene expression and neoplastic disorders, however, the molecular mechanisms of this association are not well understood. The aim of this review was to conduct a comprehensive literature search in order to understand the possible underlying molecular mechanisms of this association. We also discuss their application as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.

Evidence Acquisitions:

We searched Pubmed (NLM) and Web of Science (ISI Web of Knowledge).

Results:

S100 genes display a complex expression pattern in colorectal and hepatocel lular carcinoma. They are expressed in tumor and/or tumor stroma cells, and they exert both pro- and antitumorigenic actions. In view of this complexity, it becomes clear that S100 proteins might act as both friend and foe. The biological role of the S100 genes is predicted to depend on the relative contributions of the different cell types at specific stages of tumor progression.

Conclusions:

Further research is required in order to uncover the functional role of S100 genes in tumorigenesis. Answers to this issue are needed before we can more fully understand the clinical relevance of S100 protein expression within epithelial tumors, with regard to their potential applicability as biomarkers for diagnosis and therapy decisions.

Full Text

Full text is available in PDF

Similar Articles

25
Jun
2022
Int J Cancer Manag

FOXA1, FOXA2, SOX10 and GAS2 Gene Expression in Oral Squamous Cell Carcinoma and Their Relationship with Clinicopathological Indices

Mohadeseh Haghirizadeh,
Donya yousefi,
Hossein Fahimi,
Sepideh Khaleghi,
Mehrdad Hashemi

Haghirizadeh M, yousefi D, Fahimi H, Khaleghi S, Hashemi M. FOXA1, FOXA2, SOX10 and GAS2 Gene Expression in Oral Squamous Cell Carcinoma and Their Relationship with Clinicopathological Indices. Int J Cancer Manag. 2022;15(5):e117086. doi: https://doi.org/10.5812/ijcm-117086

23
Jul
2016

Biochemical Markers in Neurocritical Care

Omidvar Rezae,
Kurosh Gharagozli,
Hosseinali Jelvehmoghadam,
Reza Goharani,
Mohammadreza Hajiesmaeili

Rezae O, Gharagozli K, Jelvehmoghadam H, Goharani R, Hajiesmaeili M. Biochemical Markers in Neurocritical Care. J Cell Mol Anesth. 2016;1(3):e149510. doi: https://doi.org/10.22037/jcma.v1i3.11742

11
Oct
2012

The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma

Nuray Bassullu,
Ilknur Turkmen,
Murat Dayangac,
Pinar Yagiz Korkmaz,
Reyhan Yasar,
Murat Akyildiz
,et al.

Bassullu N, Turkmen I, Dayangac M, Yagiz Korkmaz P, Yasar R, et al. The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma. Hepat Mon. 2012;12(10):7492. doi: https://doi.org/10.5812/hepatmon.7492

7
Apr
2023
Int J Cancer Manag

Identification of Liver Cancer Driver Mutations from COSMIC Data

Amna Amin Sethi,
Nisar Ahmed Shar

Sethi AA, Shar NA. Identification of Liver Cancer Driver Mutations from COSMIC Data. Int J Cancer Manag. 2023;16(1):e131281. doi: https://doi.org/10.5812/ijcm-131281

15
Dec
2014

Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression

Man Ru Bi,
Li Ying Zhu,
Bing Zhu Yan,
Li Yan Chen,
Fu Xiang Wang,
Ying Ji Ma
,et al.

Bi MR, Zhu LY, Yan BZ, Chen LY, Wang FX, et al. Association of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression. Hepat Mon. 2014;14(12):e23552. doi: https://doi.org/10.5812/hepatmon.23552


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles